This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines | MicrobiomeTrials
← Back to trials NCT07756580
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-08-10Est. Completion: 2027-03
Enrollment target: 120 participantsLocations Advanced Research Associates - Glendale /ID# 283833, Glendale, Arizona, United States Eye Research Foundation /ID# 283835, Newport Beach, California, United States Pacific Clinical Innovations /ID# 283812, Vista, California, United States Etre, Cosmetic Dermatology And Laser Center /ID# 283831, New Orleans, Louisiana, United States Skincare Physicians /ID# 283851, Chestnut Hill, Massachusetts, United States Wilmington Dermatology Center /ID# 283853, Wilmington, North Carolina, United States Tennessee Clinical Research Center /ID# 283894, Nashville, Tennessee, United States Austin Institute for Clinical Research - Pflugerville /ID# 283817, Pflugerville, Texas, United States Other microbiome trials you might be interested in Moderate to Severe Glabellar Lines
The purpose of this study is to assess the effectiveness and safety of Corabotase (also known as IPN10200) compared to p…
Birmingham, United States Est. completion Dec 15, 2026
Moderate to Severe Glabellar Lines
The purpose of this study is to assess the effectiveness and safety of a single dose of Corabotase (also known as IPN102…
Los Angeles, United States Est. completion Dec 15, 2026